Physician profile
Michael D Cafone
NPI 1588663728
$3,659.74
in general payments reported to CMS, 2019-2025
13 companies · $445 in 2025
The $445 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $337 · 2021: $847 · 2022: $405 · 2023: $785 · 2024: $451 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $1,463.41 | 2019-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $917.61 | 2019-2025 | Penmenvy, Bexsero, Pediarix |
| Corium, LLC | $299.97 | 2022-2024 | Azstarys |
| Supernus Pharmaceuticals, INC. | $270.43 | 2021-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $160.52 | 2020-2022 | |
| Tris Pharma INC | $139.84 | 2019-2024 | Dyanavel Xr |
| Medtronic, INC. | $126.30 | 2025 | Minimed 780g |
| Collegium Pharmaceutical, INC. | $91.27 | 2025 | Jornay Pm |
| Pfizer INC. | $69.49 | 2019-2023 | |
| Cranial Technologies, INC | $53.18 | 2020-2022 | |
| Adlon Therapeutics L.P. | $25.92 | 2021 | |
| Sanofi Pasteur INC. | $23.90 | 2024 | |
| Alkermes, INC. | $17.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cafone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.